Italia - italiano - Ministero della Salute

desa pharma srl -

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

substipharm - ebastina - ebastina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

dipharma arzneimittel gmbh - nitisinone - nitisinone

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Italia - italiano - Ministero della Salute

pharmaidea srl -

Italia - italiano - Ministero della Salute

pharma ouest industries - protezioni per tallone, gomito e ginocchio

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ratiopharm gmbh - diclofenac - diclofenac

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ratiopharm gmbh - paracetamolo - paracetamolo

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ratiopharm gmbh - fluoxetina - fluoxetina

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

ratiopharm gmbh - captopril - captopril